APA (7th ed.) Citation

Khetan, R., Lokman, N. A., Eldi, P., Price, Z. K., Oehler, M. K., Brooks, D. A., . . . Albrecht, H. (2025). Protease-Activated Receptor F2R Is a Potential Target for New Diagnostic/Prognostic and Treatment Applications for Patients with Ovarian Cancer. International Journal of Molecular Sciences, 26(17), 8529. https://doi.org/10.3390/ijms26178529

Chicago Style (17th ed.) Citation

Khetan, Riya, et al. "Protease-Activated Receptor F2R Is a Potential Target for New Diagnostic/Prognostic and Treatment Applications for Patients with Ovarian Cancer." International Journal of Molecular Sciences 26, no. 17 (2025): 8529. https://doi.org/10.3390/ijms26178529.

MLA (9th ed.) Citation

Khetan, Riya, et al. "Protease-Activated Receptor F2R Is a Potential Target for New Diagnostic/Prognostic and Treatment Applications for Patients with Ovarian Cancer." International Journal of Molecular Sciences, vol. 26, no. 17, 2025, p. 8529, https://doi.org/10.3390/ijms26178529.